Tweed: Coming to a German Pharmacy Near You

By
Maureen Meehan

Ontario-based Canopy Growth Corporation recently announced that its subsidiary, Tweed, Inc. has been approved to begin exporting medical cannabis to Germany, according to a company press release.

The move is seen as an important milestone for Canopy Growth, as it is the first time dried cannabis is being exported from a Canadian producer to a European country.

“Introducing Tweed product to German medical cannabis patients is an exciting and groundbreaking event,” said Bruce Linton, Chairman and CEO of Canopy Growth. “Patients will soon have a new choice in variety for their medical cannabis, and we are honored to be involved in the changing landscape for German access and choice.”

While Germans can purchase MMJ in pharmacies for a variety of medical conditions, there is no domestic cannabis production as of yet.

“Until government-controlled cultivation in Germany is established, which presupposes cannabis agency, the medical cannabis supply will be covered by import, German Health Minister Hermann Gröhe told RT News, adding that pot was mainly imported from the Netherlands.

Now Tweed will pick up the slack, as it intends to initially export two strains with the potential to expand as opportunities arise.

“This is a very substantial market, and it’s probably the best place to enter the European Union from,” Linton told New Cannabis Ventures.

In other good news for Canopy Growth Corporation, the company announced it had received final approval to list its shares on the Toronto Stock Exchange (TSX).

“Being the first cannabis producing company in North America listed on a major exchange such as the TSX strengthens the sector and helps signal that the world’s view of cannabis has finally shifted, starting right here in Canada,” Linton said in a statement reported by Market Watch.

After being warmly welcomed into German pharmacies and now by the Toronto Stock Exchange, Canopy’s shares jumped 14 percent—up 9.1 percent this year—on track for a third annual advance, according to Bloomberg News.

Maureen Meehan

Maureen Meehan is a New York-based writer, who has worked as a foreign correspondent for many years.

By
Maureen Meehan

Recent Posts

Is Hop Latent Viroid Everywhere?

We examine whether smaller, isolated grows might be safer when it comes to spreading disease.

19 hours ago

Connecticut House Approves Bill Regulating Hemp Products

Connecticut lawmakers have passed legislation to regulate hemp products, including a provision that sets a…

2 days ago

Friends Don’t Let Friends Jump Through Loopholes

It’s time to take a stand against gas station weed.

2 days ago

Hemp Clothing Market to Hit $23B by 2031, Report Predicts

The hemp clothing industry is making a resurgence as a popular textile choice.

2 days ago

Clinical Trial To Assess LSD Microdosing For PMS

An Australian biopharma company said Thursday that it has received approval to begin a series…

2 days ago

Survey: High-THC Flower Yields Few Serious Side Effects in Patients

Medical cannabis patients who were administered high-THC marijuana flower found the experience to be both…

2 days ago